CLOs on the Move

Homeward Health

www.homewardhealth.com

 
Homeward is rearchitecting rural health and care for the 60 million Americans living in rural communities. Homeward employs a multidisciplinary care team, available both virtually and on the ground via mobile care units, with in-home remote monitoring to better connect patients to high-quality, affordable and comprehensive care. Today, the company partners with Medicare Advantage plans, taking on the full risk of their members to improve outcomes and reduce costs.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Brian Vandenberg
Chief Administrative Officer and General Counsel Profile

Similar Companies

intra-op monitoring services

intra-op monitoring services is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Covington, LA. To find more information about intra-op monitoring services, please visit www.iomservices.com

PharmSupport

PharmSupport is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pacific Health Care Supplies

Pacific Health Care Supplies is a Richmond, BC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Washington Health System

Washington Health System provides an integrated healthcare system centered around patients and families. They have been dedicated to providing the highest quality care since 1897. With locations throughout Washington and Greene counties in Pennsylvania...

StemCells

StemCells, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery primarily in the United States. Its lead therapeutic product candidate, HuCNS-SC cells (purified human neural stem cells), is in development as a potential treatment for a range of central nervous system disorders. The company has conducted a Phase I clinical trial in Pelizaeus-Merzbacher disease, a fatal myelination disorder in children. It is also conducting a Phase I/II clinical trial in chronic spinal cord injury; and has initiated a Phase I/II clinical trial in dry age-related macular degeneration, as well as is pursuing preclinical studies in Alzheimer’s disease. In addition, the company markets a rage of proprietary cell culture products, research grade human cells, and antibody reagents under the SC Proven brand. The proprietary cell culture products include iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff227, NDiff N2, and NDiff N27 supplements, as well as HEScGRO and ESGRO Complete; and antibody reagents comprise STEM24, STEM101, STEM121, and STEM123, which can be used for cell detection, isolation, and characterization. Further, StemCells is involved in developing and commercializing applications of its technologies to enable stem cell-based research. The company sells its tools and technologies products to researchers at academic institutions, pharmaceutical and biotechnology companies, and government laboratories. StemCells, Inc. was founded in 1988 and is headquartered in Newark, California.